Benzocyanine compounds
US-10125120-B2 · Nov 13, 2018 · US
US10351551B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10351551-B2 |
| Application number | US-201715817561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 20, 2017 |
| Priority date | Dec 21, 2010 |
| Publication date | Jul 16, 2019 |
| Grant date | Jul 16, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.
Opening claim text (preview).
What is claimed is: 1. A compound of general formula I where each of R 1 and R 2 is sulfoalkyl; X is selected from the group consisting of -NETS (hydroxysuccinimidyl), -O-TFP (2,3,5,6-tetrafluorophenoxy), -NR-L-maleimide and combinations thereof where R is —H or an aliphatic or heteroaliphatic group, and L is selected from the group consisting of a divalent linear, crossed, and cyclic alkyl group optionally substituted by at least one oxygen atom and/or sulfur atom; Kat is one or more cations necessary to balance the negative charge of the compound; m is 0; o is 3; and n is 1, 2 or 3, conjugated to a biomolecule selected from at least one of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factor, toxin, biological cell, lipid, receptor binding drug, organic polymer carrier material, or inorganic polymeric carrier material. 2. A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to bind to at least one biomolecule, resulting in the compound of claim 1 being bound to the at least one biomolecule. 3. The method of claim 2 wherein the biomolecule is selected from the group consisting of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, or inorganic polymeric carrier material. 4. A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to bind to at least one biomolecule, resulting in the compound of claim 1 being bound to the at least one biomolecule, and detecting the biomolecule-bound compound. 5. The method of claim 4 wherein the biomolecule is selected from a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, or inorganic polymeric carrier material. 6. The method of claim 4 wherein the at least one biomolecule is detected in an assay selected from fluorescence microscopy, flow cytometry, in vivo imaging, immunoassay, hybridization, chromatographic assay, electrophoretic assay, microwell plate based assay, fluorescence resonance energy transfer (FRET) system, high throughput screening, or microarray. 7. The method of claim 4 wherein when the biomolecule is detected by in vivo imaging, the method comprises providing the biomolecule-bound compound to at least one of a biological sample, tissue, or organism, and detecting the biomolecule within the at least one of a biological sample, tissue, or organism. 8. A kit for performing an assay to detect at least one biomolecule in a sample, the kit comprising the compound of claim 1 and at least one excipient, and instructions for use.
with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.